Results 151 to 160 of about 6,801 (167)

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Lancet, The, 2011
Sebahattin Cirak, V Arechavala-Gomeza, Michela Guglieri   +2 more
exaly  

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

Lancet, The, 2015
Thomas Voit, Janbernd Kirschner, Richard S Finkel   +2 more
exaly  

Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy

Lancet, The, 1994
Sylvie Chevret
exaly  

Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study

Lancet, The, 1999
exaly  

Prevalence and incidence of Becker muscular dystrophy

Lancet, The, 1991
exaly  

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2017
Craig M Mcdonald, Craig Campbell, Linda P Lowes   +2 more
exaly  

Limitation of eye movement in merosin-deficient congenital muscular dystrophy

Lancet, The, 1999
exaly  

Location of facioscapulohumeral muscular dystrophy gene on chromosome 4

Lancet, The, 1990
exaly  

PREDNISONE IN DUCHENNE MUSCULAR DYSTROPHY

Lancet, The, 1974
exaly  

Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy

Lancet, The, 1996
exaly